Trial
NCT00372905
Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
Robert H. Lurie Cancer Center
Condition
Lymphoma
Intervention
rituximab
Why stopped
Study was closed permanently before the accrual goal was met due to slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-04